Further evidence for aberrant prefrontal salience coding in schizophrenia

Frontiers in Behavioral Neuroscience

Volumn 3, Issue FEB, 2010, Pages

  Walter, Henrik ^a,b   Heckers, Stephan ^c   Kassubek, Jan ^d   Erk, Susanne ^a,b   Frasch, Karel ^d   Abler, Birgit ^d  

^a UNIVERSITY OF BONN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Dopamine; Functional magnetic resonance imaging; Reward; Salience; Schizophrenia

Indexed keywords

EID: 79951505598     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.08.062.2009     Document Type: Article

References (36)

1. Abler, B., Erk, S., and Walter, H. (2007). Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology (Berl.) 191, 823-833.
2. Abler, B., Greenhouse, I., Ongur, D., Walter, H., and Heckers, S. (2008). Abnormal reward system activation in mania. Neuropsychopharmacology 33, 2217-2227.
3. Abler, B., Hahlbrock, R., Unrath, A., Gron, G., and Kassubek, J. (2009). At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain 132, 2396-2402.
4. Abler, B., Walter, H., and Erk, S. (2005). Neural correlates of frustration. Neuroreport 16, 669-672.
5. Abler, B., Walter, H., Erk, S., Kammerer, H., and Spitzer, M. (2006). Prediction error as a linear function of reward probability is coded in human nucleus accumbens. Neuroimage 31, 790-795.
6. Arana, F.S., Parkinson, J.A., Hinton, E., Holland, A.J., Owen, A. M., and Roberts, A. C. (2003). Dissociable contributions of the human amygdala and orbitofrontal cortex to incentive motivation and goal selection. J. Neurosci. 23, 9632-9638.
7. Berridge, K. C., and Robinson, T.E. (2003). Parsing reward. Trends Neurosci. 26, 507-513.
8. Carlsson, A., and Lindqvist, M. (1963). Effect of chlorpromazine or haloperidol on formation of 3 methoxytyramine and norme-tanephrine in mouse brain. Acta Pharmacol. Toxicol. (Copenh) 20, 140-144.
9. Carlsson, A., Waters, N., Waters, S., and Carlsson, M. L. (2000). Network interactions in schizophrenia - therapeutic implications. Brain Res. Brain Res. Rev. 31, 342-349.
10. Chapman, L. J., Chapman, J. P., and Raulin, M. L. (1976). Scales for physical and social anhedonia. J. Abnorm Soc. Psychol. 85, 374-382.
11. Cools, R., Clark, L., Owen, A. M., and Robbins, T. W. (2002). Defi ning the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J. Neurosci. 22, 4563-4567.
12. Cooper, J. C., and Knutson, B. (2008). Valence and salience contribute to nucleus accumbens activation. Neuroimage 39, 538-547.
13. Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R., Shanks, D. R., Robbins, T. W., Bullmore, E. T., Dickinson, A., and Fletcher, P. C. (2007). Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain 130, 2387-2400.
14. Goel, V., and Vartanian, O. (2005). Dissociating the roles of right ventral lateral and dorsal lateral prefrontal cortex in generation and maintenance of hypotheses in set-shift problems. Cereb. Cortex 15, 1170-1177.
15. Guillin, O., Abi-Dargham, A., and Laruelle, M. (2007). Neurobiology of dopamine in schizophrenia. Int. Rev. Neurobiol. 78, 1-39.
16. Heinz, A. (2002). Dopaminergic dysfunction in alcoholism and schizophrenia--psychopathological and behavioral correlates. Eur. Psychiatry 17, 9-16.
17. Jensen, J., Smith, A. J., Willeit, M., Crawley, A. P., Mikulis, D. J., Vitcu, I., and Kapur, S. (2007). Separate brain regions code for salience vs. valence during reward prediction in humans. Hum. Brain Mapp. 28, 294-302.
18. Jensen, J., Willeit, M., Zipursky, R. B., Savina, I., Smith, A. J., Menon, M., Crawley, A. P., and Kapur, S. (2008). The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33, 473-479.
19. Juckel, G., Schlagenhauf, F., Koslowski, M., Filonov, D., Wustenberg, T., Villringer, A., Knutson, B., Kienast, T., Gallinat, J., Wrase, J., and Heinz, A. (2006). Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neu-roleptics. Psychopharmacology (Berl.) 187, 222-228.
20. Juckel, G., Schlagenhauf, F., Koslowski, M., Wustenberg, T., Villringer, A., Knutson, B., Wrase, J., and Heinz, A. (2006). Dysfunction of ventral stri-atal reward prediction in schizophrenia. Neuroimage 29, 409-416.
21. Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 160, 13-23.
22. Kapur, S., Agid, O., Mizrahi, R., and Li, M. (2006). How antipsychotics work-from receptors to reality. NeuroRx 3, 10-21.
23. Kay, S. R., Fiszbein, A., and Opler, L. A. (1987). The positive and negative syndrome scale, PANSS for schizophrenia. Schizophr. Bull. 13, 261-276.
24. Knutson, B., and Cooper, J. C. (2005). Functional magnetic resonance imaging of reward prediction. Curr. Opin. Neurol. 18, 411-417.
25. Knutson, B., Fong, G. W., Adams, C. M., Varner, J. L., and Hommer, D. (2001). Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 12, 3683-3687.
26. Macdonald, A. W., III, Thermenos, H. W., Barch, D. M., and Seidman, L. J. (2008). Imaging genetic liability to schizophrenia: systematic review of fMRI studies of patients' nonpsy-chotic relatives. Schizophr Bull. 35, 1142-1162.
27. Müller, M. J. (2002). Positive and Negative Syndrome Scale (PANSS). In: Diagnostische Verfahren in der Psychotherapie. Diagnostik für Klinik und Praxis, Band 1. E. J. Brähler, and B. Schumacher Strauß, eds (Hogrefe, Göttingen).
28. Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., and Fletcher, P. C. (2008). Substantia nigra/ventral teg-mental reward prediction error disruption in psychosis. Mol. Psychiatry 13:239, 267-276.
29. Ritter, L. M., Meador-Woodruff, J. H., and Dalack, G. W. (2004). Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia. Schizophr. Res. 68, 65-73.
30. Scherbarth-Roschmann, P., and Hautzinger, M. (1991). Zur psycho-metrischen Erfassung von Schizotypie: Methodische Überprüfung und erste Validierung von zwei Skalen zur Erfassung von Risikomerkmalen. Zeitschrift für Klinische Psychologie 20, 238-250.
31. Schlagenhauf, F., Sterzer, P., Schmack, K., Ballmaier, M., Rapp, M., Wrase, J., Juckel, G., Gallinat, J., and Heinz, A. (2009). Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol. Psychiatry 65, 1032-1039.
32. Spitzer, M. (1997). A cognitive neu-roscience view of schizophrenic thought disorder. Schizophr. Bull. 23, 29-50.
33. Walter, H., Kammerer, H., Frasch, K., Spitzer, M., and Abler, B. (2009). Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. Psychopharmacology (Berl) 206, 121-132.
34. Waltz, J. A., and Gold, J. M. (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr. Res. 93, 296-303.
35. Wise, R. A., Spindler, J., deWit, H., and Gerberg, G. J. (1978). Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science 201, 262-264.
36. Yacubian, J., Glascher, J., Schroeder, K., Sommer, T., Braus, D. F., and Buchel, C. (2006). Dissociable systems for gain-and loss-related value predictions and errors of prediction in the human brain. J. Neurosci. 26, 9530-9537.